Found: 5
Select item for more details and to access through your institution.
Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1159, doi. 10.1007/s00262-008-0610-6
- By:
- Publication type:
- Article
Low TCR avidity and lack of tumor cell recognition in CD8<sup>+</sup> T cells primed with the CEA-analogue CAP1-6D peptide.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 12, p. 1979, doi. 10.1007/s00262-007-0342-z
- By:
- Publication type:
- Article
Vaccination therapy in prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 429, doi. 10.1007/s00262-006-0233-8
- By:
- Publication type:
- Article
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e690, doi. 10.1093/oncolo/oyad342
- By:
- Publication type:
- Article
pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 1, p. 207, doi. 10.1002/ijc.25009
- By:
- Publication type:
- Article